Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Elizabeth A, Scoville"'
Autor:
Jia Li, Alan J. Simmons, Caroline V. Hawkins, Sophie Chiron, Marisol A. Ramirez-Solano, Naila Tasneem, Harsimran Kaur, Yanwen Xu, Frank Revetta, Paige N. Vega, Shunxing Bao, Can Cui, Regina N. Tyree, Larry W. Raber, Anna N. Conner, Jennifer M. Pilat, Justin Jacobse, Kara M. McNamara, Margaret M. Allaman, Gabriella A. Raffa, Alain P. Gobert, Mohammad Asim, Jeremy A. Goettel, Yash A. Choksi, Dawn B. Beaulieu, Robin L. Dalal, Sara N. Horst, Baldeep S. Pabla, Yuankai Huo, Bennett A. Landman, Joseph T. Roland, Elizabeth A. Scoville, David A. Schwartz, M. Kay Washington, Yu Shyr, Keith T. Wilson, Lori A. Coburn, Ken S. Lau, Qi Liu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Crohn’s disease (CD) is a complex chronic inflammatory disorder with both gastrointestinal and extra-intestinal manifestations associated immune dysregulation. Analyzing 202,359 cells from 170 specimens across 83 patients, we identify a di
Externí odkaz:
https://doaj.org/article/0ba81d63e38741479e8c66302f19cf18
Autor:
J. Randall Patrinely, Ben McGuigan, Sunandana Chandra, Sarah E. Fenton, Akansha Chowdhary, Lucy B. Kennedy, Meghan J. Mooradian, Marisa Palmeri, Daniella Portal, Sara N. Horst, Elizabeth A. Scoville, Georgina V. Long, Chanjuan Shi, Janice M. Mehnert, Ryan J. Sullivan, April K. Salama, Jeffrey A. Sosman, Alexander M. Menzies, Douglas B. Johnson
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Immune checkpoint inhibitors (ICI) predispose patients to immune-related adverse events (irAEs). Although hepatitis is a potentially lethal toxicity, the timing and outcomes have not been well described. In this retrospective study, patients from six
Externí odkaz:
https://doaj.org/article/de26ed8c2f814f73ad812c4ee03fc68d
Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study.
Autor:
Elizabeth A Scoville, Hilary A Tindle, Quinn S Wells, Shannon C Peyton, Shelly Gurwara, Stephanie O Pointer, Sara N Horst, David A Schwartz, Dawn W Adams, Matthew S Freiberg, Vanessa Gatskie, Stephen King, Lesa R Abney, Dawn B Beaulieu
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0230656 (2020)
IntroductionSmoking is a strong risk factor for disease severity in Crohn's disease (CD) and cessation improves outcomes. The nicotine metabolite ratio (NMR) predicts cessation success with pharmacotherapy: varenicline doubles cessation over nicotine
Externí odkaz:
https://doaj.org/article/3a70b9d4295e41a480d2c2d27ccfe6c2
Autor:
Andres Yarur, Freddy Caldera, Sirimon O'Charoen, Joshua R. Korzenik, Cecile Norris, Matthew Bohm, Monika Fischer, Sara Sweeney, Alandra Weaver, Uni Wong, Sushila Dalal, Themistocles Dassopoulos, Katerina Wells, David Hudesman, Lilani P. Perera, Shrinivas Bishu, Caren Heller, Richard H. Duerr, Tara Fehlmann, Deepak Parakkal, Raymond K. Cross, James D. Lewis, Manreet Kaur, Matthew A. Ciorba, Sumona Saha, Elizabeth A. Scoville, Laura E. Raffals, Joel Pekow, Scott B. Snapper, Angela Dobes, Meenakshi Bewtra
Publikováno v:
Inflamm Bowel Dis
Background Clinical and molecular subcategories of inflammatory bowel disease (IBD) are needed to discover mechanisms of disease and predictors of response and disease relapse. We aimed to develop a study of a prospective adult research cohort with I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdddd093b9db869b8411122566803360
https://doi.org/10.1093/ibd/izab071
https://doi.org/10.1093/ibd/izab071
Autor:
Sara N. Horst, Robin Dalal, C. Alex Wiles, David A. Schwartz, Dawn B. Beaulieu, Elizabeth A. Scoville, James C. Slaughter, Baldeep S. Pabla
Publikováno v:
Digestive Diseases and Sciences. 67:3129-3137
Vedolizumab is a monoclonal antibody used to treat inflammatory bowel disease (IBD). There is little known about the safety and comparative efficacy of this agent in the elderly population. Here, we present data on the safety and comparative efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f5facf3ace00a6784aa792696cfc7eb
https://doi.org/10.1007/s10620-021-07129-5
https://doi.org/10.1007/s10620-021-07129-5
Autor:
Dawn B. Beaulieu, David A. Schwartz, Elizabeth A. Scoville, Kim Annis, Alexander P. Mamunes, Ailish Garrett, Robin Dalal, Caroline Duley, Sara N. Horst, Mindy Kim, Audrey L. Bennett, Julianne H. Wagnon
Publikováno v:
Inflammatory Bowel Diseases. 28:409-414
Background Prior research demonstrates Crohn’s disease patients often do well in pregnancy; however, less is known about the risk of flare in the postpartum period. Methods A retrospective chart review was conducted at a tertiary care inflammatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3fe16616cea305b888b17268eccb62
https://doi.org/10.1093/ibd/izab104
https://doi.org/10.1093/ibd/izab104
Autor:
Dawn B. Beaulieu, Roman E Gusdorf, Robin Dalal, Austin J. Triana, Kaustav P. Shah, Sara N. Horst, Allison B. McCoy, David A. Schwartz, Baldeep S. Pabla, Elizabeth A. Scoville, Michelle L. Griffith
Publikováno v:
Inflammatory Bowel Diseases. 28:358-363
Background This study evaluated synchronous audiovisual telehealth and audio-only visits for patients with inflammatory bowel disease (IBD) to determine frequency of successful telehealth visits and determine what factors increase the likelihood of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c87e85a5dd3c6f3ca5b1557d2f19750
https://doi.org/10.1093/ibd/izab068
https://doi.org/10.1093/ibd/izab068
Autor:
James C. Slaughter, Dawn B. Beaulieu, Miles Basil, Michael F. Vaezi, Tina Higginbotham, Sara N. Horst, Dawn W. Adams, Elizabeth A. Scoville, Robin Dalal, Yash A. Choksi, David A. Schwartz
Publikováno v:
Digestive Diseases and Sciences. 67:639-645
While the pathogenesis of inflammatory bowel disease (IBD) is incompletely understood, disruption of epithelial integrity is suspected to play a prominent role in disease initiation and progression. Currently, there is no convenient way to measure th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff47dfff63bcd859b76147e5eaf6965
https://doi.org/10.1007/s10620-021-06888-5
https://doi.org/10.1007/s10620-021-06888-5
Autor:
Nisha B Shah, Robin Dalal, Elizabeth A. Scoville, Jake Bell, Sara N. Horst, C. Alex Wiles, Dawn B. Beaulieu, Baldeep S. Pabla, David A. Schwartz
Publikováno v:
Crohn's & Colitis 360. 3
Background Tofacitinib has been approved for moderate-to-severe ulcerative colitis and studied in Crohn’s disease. Understanding medication adherence to oral medications in severe disease is essential. Methods We retrospectively reviewed adherence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea1285201cbf85cdf3505847287fcb56
https://doi.org/10.1093/crocol/otab075
https://doi.org/10.1093/crocol/otab075
Autor:
Marisol A. Ramirez, Joseph T. Roland, Ho Hin Lee, Sophie Chiron, Austin N. Southard-Smith, Yuankai Huo, Keith T. Wilson, Ken S. Lau, Elizabeth A. Scoville, Bennett A. Landman, Lori A. Coburn, Cody N. Heiser, Mary Kay Washington, Yucheng Tang, Qi Liu, Shunxing Bao
Publikováno v:
Proc SPIE Int Soc Opt Eng
The Gut Cell Atlas (GCA), an initiative funded by the Helmsley Charitable Trust, seeks to create a reference platform to understand the human gut, with a specific focus on Crohn’s disease. Although a primary focus of the GCA is on focusing on singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181a4b314f647f01e974382ea96e729c
https://pubmed.ncbi.nlm.nih.gov/34539029
https://pubmed.ncbi.nlm.nih.gov/34539029